Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 15
393
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Analysis of chemical components in herbal formula Qi Bai Granule by UPLC-ESI-Q-TOF-MS

, , , , , & show all
Pages 2271-2275 | Received 01 Apr 2018, Accepted 28 Jun 2018, Published online: 16 Nov 2018

Reference

  • Chen Y, Kang Z, Yan J, Yang GP, Tan ZR, Zhou G, Ouyang DS. 2010. Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. J Ethnopharmacol. 132:213–218.
  • Gao D, Wang B, Huo Z, He Y, Polachi N, Lei Z, Liu X, Song Z, Qi LW. 2017. Analysis of chemical constituents in an herbal formula Jitong Ning Tablet. J Pharm Biomed Anal. 140:301–312.
  • Kim EH, Seo HS, Ki NY, Park NH, Lee W, Do JA, Park S, Baek SY, Moon B, Oh HB. 2017. Reliable screening and confirmation of 156 multi-class illegal adulterants in dietary supplements based on extracted common ion chromatograms by ultra-high-performance liquid chromatography-quadrupole/time of flight-mass spectrometry. J Chromatogr A. 1491:43–56.
  • Wang L, Li Y, Hou M. 2007. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis. Crit Rev Oncol Hematol. 64:83–89.
  • Wang X, Zhang H, Chen L, Shan L, Fan G, Gao X. 2013. Liquorice, a unique ‘guide drug’ of traditional Chinese medicine: a review of its role in drug interactions. J Ethnopharmacol. 150:781–790.
  • Wu Y, Peng J, Chen W, Ye Y, Liang D. 2011. Gui Pi Pills’ effect on platelet: associated antibodies of patients with chronic idiopathic thrombocytopenic purpura. Modern Tradit Chin Med. 31:1–3.
  • Zhou Z, Yang R. 2008. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura. Crit Rev Oncol Hematol. 65:21–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.